ArticleMolecular diversity2026
MSCA-PLA: multi-scale cross-attention with differentiable pooling for protein-ligand binding affinity prediction.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurately predicting protein-ligand binding affinity is essential for drug discovery. However, protein-ligand binding involves not only pairwise atomic contacts but also synergistic effects between atomic clusters; meanwhile, adaptively identifying which atoms can form effective atomic clusters to drive protein-ligand interactions remains a key challenge. To address this challenge, we propose MSCA-PLA, a multi-scale cross-attention framework with differentiable pooling for protein-ligand binding affinity prediction. Specifically, MSCA-PLA adaptively aggregates atom-level embeddings into binding-relevant atom clusters through differentiable pooling, and performs cluster-level cross-attention between protein and ligand clusters to model cooperative interactions among atom groups. Meanwhile, an atom-level bidirectional cross-attention module is employed to preserve fine-grained pairwise atomic contacts at the binding interface. Furthermore, to effectively integrate interaction information from different scales, we design a staged gated fusion strategy. Experiments on multiple benchmark datasets, diverse-protein settings, virtual-screening tasks, and a small external structural subset support the effectiveness of MSCA-PLA across the evaluated settings.
Indexed as
Identifiers
42584523What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.